| ||||||||||||||
|
|
|||||||||||||
Received from the Department of Anaesthesia, Foothills Hospital at the University of Calgary, Calgary, Alberta, Canada.
Abstract
Local anesthetic toxicity and cardiovascular stress during fiberoptic-assisted awake tracheal intubation were assessed prospectively in 20 patients with airway management problems. Cardiovascular responses, dose of lidocaine, its systemic absorption, and patient comfort were measured. A standardized topical anesthesia protocol of 4% lidocaine aerosol, topical 2% lidocaine viscous gel, and direct perbronchoscopic laryngeal application was used. Awake intubation produced no significant elevation of blood pressure or pulse rate either during the topical application or after the intubation. Despite a large total dose of topical lidocaine (5.3 ± 2.1 mg/kg), the mean peak arterial plasma lidocaine concentration was low (0.6 ± 2.1 µg/ml). Patient comfort assessment showed that nine patients had no discomfort, whereas 11 had minimal discomfort. Supplementary sedation used was minimal (fentanyl, 1.4 ± 0.6 µg/kg, and diazepam, 1.9 ± 1.8 mg). This method of producing topical anesthesia for awake tracheal intubation is recommended as a safe, easy, and comfortable method of managing patients with airway difficulties.
Key Words: INTUBATION—tracheal EQUIPMENT—fiberoptic bronchoscope
This article has been cited by other articles:
![]() |
N. M. Woodall, R. J. Harwood, and G. L. Barker Complications of awake fibreoptic intubation without sedation in 200 healthy anaesthetists attending a training course Br. J. Anaesth., June 1, 2008; 100(6): 850 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tan, P. Swart, P. Lennox, and H. Vaghadia 26391 - SEDATION FREE AWAKE FIBREOPTIC INTUBATION USING ATOMISED 1% COCAINE AND 3% LIDOCAINE Can J Anesth, June 1, 2006; 53(suppl_1): 26391 - 26391. [Full Text] [PDF] |
||||
![]() |
K. A. Williams, G. L. Barker, R. J. Harwood, and N. M. Woodall Combined nebulization and spray-as-you-go topical local anaesthesia of the airway Br. J. Anaesth., October 1, 2005; 95(4): 549 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hamard, M. Ferrandiere, X. Sauvagnac, J. C. Mangin, J. Fusciardi, C. Mercier, and M. Laffon La sedation au propofol permet l'intubation difficile vigile avec le masque larynge FastrachTM: [Propofol sedation allows awake intubation of the difficult airway with the FastrachTM LMA] Can J Anesth, April 1, 2005; 52(4): 421 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Machata, C. Gonano, A. Holzer, D. Andel, C. K. Spiss, M. Zimpfer, and U. M. Illievich Awake Nasotracheal Fiberoptic Intubation: Patient Comfort, Intubating Conditions, and Hemodynamic Stability During Conscious Sedation with Remifentanil Anesth. Analg., September 1, 2003; 97(3): 904 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Joo, S. Kapoor, D. K. Rose, and V. N. Naik The Intubating Laryngeal Mask Airway After Induction of General Anesthesia Versus Awake Fiberoptic Intubation in Patients with Difficult Airways Anesth. Analg., May 1, 2001; 92(5): 1342 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Andel, G. Klune, D. Andel, M. Felfernig, A. Donner, W. Schramm, and M. Zimpfer Propofol Without Muscle Relaxants for Conventional or Fiberoptic Nasotracheal Intubation: A Dose-Finding Study Anesth. Analg., August 1, 2000; 91(2): 458 - 461. [Abstract] [Full Text] [PDF] |
||||
|